CATALENT UK SUPPLY CHAIN LIMITED
Get an alert when CATALENT UK SUPPLY CHAIN LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-06-30
Confirmation statement due
2026-11-24 (in 6mo)
Last made up 2025-11-10
Watchouts
None on the register
Cash
459,808
+102.7% vs 2023
Net assets
792,410
+153.7% first positive since 2023
Employees
—
Average over period
Profit before tax
2,195,820
+137.2% highest in 4 filed years
Name history
Renamed 3 times since incorporation
- CATALENT UK SUPPLY CHAIN LIMITED 2019-02-22 → present
- JUNIPER PHARMACEUTICALS UK LIMITED 2015-04-14 → 2019-02-22
- COLUMBIA LABORATORIES (UK) LIMITED 1989-12-19 → 2015-04-14
- BURGINHALL 396 LIMITED 1989-09-25 → 1989-12-19
Net assets
4-year trend · vs Health Care median
Accounts
4-year trend · latest reflected 2024-06-30
| Metric | Trend | 2020-06-30 | 2021-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|---|---|
| Turnover | — | — | £16,678,912 | £29,236,785 | |
| Operating profit | -£88,160 | £62,775 | £553,931 | £8,644,900 | |
| Profit before tax | -£317,190 | -£165,629 | -£5,895,149 | £2,195,820 | |
| Net profit | — | — | -£5,660,067 | £2,267,880 | |
| Cash | — | — | £226,825 | £459,808 | |
| Total assets less current liabilities | £15,188,393 | £15,251,168 | -£1,378,594 | £956,638 | |
| Net assets | £1,756,459 | £1,590,830 | -£1,475,470 | £792,410 | |
| Equity | £1,756,459 | £1,590,830 | -£1,475,470 | £792,410 | |
| Average employees | 0 | 0 | — | — | |
| Wages | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-06-30 | 2021-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|---|---|
| Operating margin | — | — | 3.3% | 29.6% | |
| Net margin | — | — | -33.9% | 7.8% | |
| Return on capital employed | -0.6% | 0.4% | -40.2% | 903.7% | |
| Gearing (liabilities / total assets) | — | — | 103.6% | 98.8% | |
| Current ratio | — | — | 0.53x | 0.74x | |
| Interest cover | -0.38x | 0.27x | — | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have assessed that the company would be profitable and cash generating throughout the going concern period to 30 June 2026. The Company forecasts, taking account of reasonably possible changes in trading performance...the directors have formed a reasonable expectation...continue to operate for the foreseeable future.”
Group structure
- CATALENT UK SUPPLY CHAIN LIMITED · parent
- Catalent Nottingham Limited 100%
Significant events
- “On 18th December 2024, the ultimate parent, Catalent Inc. completed the merger agreement with Novo Holdings... Catalent shareholders voted to approve the transaction with 99.2% of ballots cast in favour...”
- “Subsequent to year end 30 June 2024, Novo Nordisk Holding A/S (Denmark), a company incorporated in Denmark, acquired 100% of issued share capital of Catalent Inc.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 26 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BARNETT, Kate Toller | Director | 2025-04-01 | Jun 1974 | British |
| CERON, Ramon Javier, Mr. | Director | 2025-04-01 | Aug 1969 | American |
| GENNADIOS, Aristippos | Director | 2025-04-01 | May 1965 | American |
Show 26 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CHAMBERS, Michael | Secretary | 1995-11-06 | 2013-12-31 |
| WALSH, Kirk | Secretary | 2018-09-27 | 2022-12-01 |
| GRAY'S INN SECRETARIES LIMITED | Corporate Nominee Secretary | — | 1995-11-06 |
| ARNOLD, Jonathan | Director | 2018-09-27 | 2022-09-14 |
| BLONDEAU, Annick | Director | 1996-06-10 | 2001-06-30 |
| BOLOGNA, William Joseph | Director | — | 2003-04-15 |
| CARLETTI, Lorenzo | Director | 2022-05-31 | 2025-04-01 |
| CARTIER, Philippe Jean | Director | 1998-10-15 | 2001-03-30 |
| CARVAIS, Jean Emmanuel Norbert | Director | 1998-10-15 | 2004-05-26 |
| CHAMBERS, Michael | Director | — | 2013-12-31 |
| CONDELLA, Frank C | Director | 2010-05-14 | 2016-07-31 |
| DICK, Colin Allister James, Mr. | Director | 2022-12-01 | 2025-04-01 |
| ELSTON, George | Director | 2014-10-01 | 2016-12-31 |
| HAWKESWOOD, Thomas | Director | 2022-09-14 | 2025-04-01 |
| HOPSON, Ricky | Director | 2022-09-14 | 2022-09-15 |
| LLOYD JONES, Jonathan Brian | Director | 2013-01-21 | 2014-10-31 |
| MASELLI, Alessandro | Director | 2018-09-27 | 2022-05-31 |
| MCGRANE, Michael | Director | 2004-06-10 | 2013-01-15 |
| MEIR, James Norman Max | Director | — | 2001-03-30 |
| MILLS JR, Robert Stephen, Senior V P And Coo | Director | 2004-06-10 | 2010-05-14 |
| NEEDHAM, David Alan, Dr | Director | — | 1993-05-21 |
| PATEL, Nikin, Dr | Director | 2014-04-14 | 2019-03-29 |
| PERCIVAL, Philip Charles | Director | — | 1992-12-31 |
| SECOR, Alicia | Director | 2016-08-01 | 2018-09-27 |
| WALSH, Kirk | Director | 2018-09-27 | 2022-12-01 |
| YOUNG, Jeffrey | Director | 2017-01-01 | 2018-09-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Catalent, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-08-13 | Active |
| Juniper Pharmaceuticals, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2018-08-13 |
Filing timeline
Last 20 of 196 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-08 | AA | accounts | Accounts with accounts type full | |
| 2025-04-17 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-17 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-17 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-17 | TM01 | officers | Termination director company with name termination date | |
| 2025-04-17 | TM01 | officers | Termination director company with name termination date | |
| 2025-04-17 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-13 | AA01 | accounts | Change account reference date company current extended | |
| 2024-11-25 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-08-07 | AA | accounts | Accounts with accounts type full | |
| 2024-01-18 | AA | accounts | Accounts with accounts type small | |
| 2024-01-17 | AAMD | accounts | Accounts amended with accounts type full | |
| 2023-12-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-20 | AP01 | officers | Appoint person director company with name date | |
| 2023-01-20 | TM01 | officers | Termination director company with name termination date | |
| 2023-01-20 | TM02 | officers | Termination secretary company with name termination date | |
| 2022-12-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-11 | TM01 | officers | Termination director company with name termination date | |
| 2022-10-10 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-06-30 vs 2023-06-30
-
Turnover
+75.3%
£16,678,912 £29,236,785
-
Cash
+102.7%
£226,825 £459,808
-
Net assets
+153.7%
-£1,475,470 £792,410
first positive since 2023
-
Employees
—
Not reported
-
Operating profit
+1,460.6%
£553,931 £8,644,900
highest in 4 filed years
-
Profit before tax
+137.2%
-£5,895,149 £2,195,820
highest in 4 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers